Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Mylan Institutional, Inc. recalls Levothyroxine Sodium Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Subpotent and Superpotent Drug
Products
  • Levothyroxine Sodium Tablets
Where it was sold

Nationwide in the USA.

Nationwide

Units affected
1,664 cartons
About this recall
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-443-20